SKP2 and colorectal cancer: Byun et al. reported that ohmyungsamycin A (Compound 1) upregulated the expression of the CDK inhibitor p27 but downregulated the expression of Skp2 and MCM4, then induced G0/G1 cell cycle in human colorectal cancer cells [23].